PD-Rx Pharmaceuticals, Inc. (PDRX)

PD-Rx Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is July - June.

Operating Activities

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Net Income	-0.26	-0.75	-0.1	3.03	1.86
Depreciation & Amortization	0.15	0.15	0.14	0.13	0.11
Loss (Gain) From Sale of Assets	0.01	0.01	0	-0.03	-0.01
Provision & Write-off of Bad Debts	0.16	0.16	0.35	0.27	0.25
Other Operating Activities	-0.02	0.04	-0.04	0.08	-0.94
Change in Accounts Receivable	0.93	-0.96	1.73	-0.83	-1.85
Change in Inventory	0.44	-0.59	0.2	0.82	-0.8
Change in Accounts Payable	-0.69	0.53	-0.17	-0.49	1.06
Change in Income Taxes	-0	-0	-0.29	0.24	-0.16
Change in Other Net Operating Assets	0.05	0.07	-0.03	0.03	0
Operating Cash Flow	0.77	-1.35	1.79	3.24	-0.47
Operating Cash Flow Growth	-	-	-44.71%	-	-

Investing Activities

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Capital Expenditures	-0	-0.08	-0.43	-0.55	-0.11
Sale of Property, Plant & Equipment	-	-	-	0.05	0.02
Investing Cash Flow	-0	-0.08	-0.43	-0.5	-0.09

Financing Activities

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Repurchase of Common Stock	-	-0	-0	-0.17	-
Financing Cash Flow	-	-0	-0	-0.17	-

Net Cash Flow

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Net Cash Flow	0.76	-1.43	1.36	2.57	-0.55

Free Cash Flow

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Free Cash Flow	0.76	-1.43	1.36	2.69	-0.57
Free Cash Flow Growth	-	-	-49.28%	-	-
Free Cash Flow Margin	4.16%	-7.54%	6.40%	9.35%	-2.66%
Free Cash Flow Per Share	0.47	-0.87	0.83	1.62	-0.33
Levered Free Cash Flow	0.73	-1.32	1.38	2.1	-0.93
Unlevered Free Cash Flow	0.73	-1.32	1.38	2.1	-0.93

Additional Metrics

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Cash Income Tax Paid	0	0.01	0.31	0.7	0.14
Change in Working Capital	0.73	-0.96	1.44	-0.24	-1.74

Data Source: S&P Global Market Intelligence Last updated: Mar 1, 2000

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 6, 2026

Data Sources Report a data error